Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2008

Jan 31, 2008

35380_dirs_2008-01-31_8f015316-1551-45f9-a5d3-2dab5dc451f7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: ORAGENICS INC (oni)
CIK: 0001174940
Period of Report: 2008-01-11

Reporting Person: HAWES GEORGE T (Director, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-01-11 warrants $0.44 P 587500 Acquired 2008-02-08 common stock (587500) Direct
2008-01-28 warrants $0.44 P 1000000 Acquired 2008-08-08 common stock (1000000) Direct
2008-01-28 warrants $0.44 P 100000 Acquired 2008-08-08 common stock (100000) Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-employee Director Options $0.74 2011-09-08 common stock (65000) 65000 Direct

Footnotes

F1: These warrants were orginally issued to the Reporting Person on March 6, 2006 at an exercise price of $0.60 per share. On January 11, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 for the period fron January 11, 2008 to February 8, 2008, which is the expiration date.

F2: These warrants were originally issued to the Reporting Person on August 8, 2007 at an exercise price of $0.58 per share. On January 28, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 during the period from January 28, 2008 to February 29, 2008. After such period, the per share exercise price reverts back to $0.58 per share during the remainder of the warrant term.

F3: These warrants were originally issued to the spouse of the Reporting Person on August 8, 2007 at an exercise price of $0.58 per share. On January 28, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 for the period from January 28, 2008 to February 29, 2008. After such period, the per share exercise price reverts back to $0.58 for the remainder of the warrant term.

F4: The Reporting Person disclaims beneficial ownership interest of such securities.